DELta Virus infection in animal and human hosts
The DELV project aims to characterize deltaviruses' biology and host interactions to inform antiviral strategies and understand their zoonotic potential and evolutionary dynamics.
Projectdetails
Introduction
The emergence and rapid transmission of viruses pose increasing risks and challenges to modern societies, threatening public health and economic stability. A thorough understanding of basic virology is therefore critical for an informed development of preventive and control strategies.
Background
Although for more than 40 years the only known member of deltaviruses was the human Hepatitis Delta virus (HDV), it was recently discovered that HDV-like agents are present in a variety of animal vectors and reservoirs including bats, rats, snakes, birds, and insects. Metagenomic data indicate that these satellite viruses possess an unrecognized host shifting capacity enabling them to cross the species barrier.
Current Challenges
As no efficient antiviral treatment is available against HDV, the emergence of novel deltaviruses poses a significant potential threat to human health. To date, animal deltaviruses have not been functionally characterized and little is known about their basic biology.
Project Aims
The proposed project (DELV) aims to generate essential knowledge about the biology of deltaviruses, their interactions with host cells, their zoonotic potential, and evolutionary fitness. The project will focus on the following aims:
-
Aim 1: Using newly generated deltavirus molecular clones coupled to unbiased proteomic and genetic approaches, DELV will identify host factors interacting with deltaviruses in their natural animal and human hosts.
-
Aim 2: DELV will determine and characterize host factors that are essential for deltavirus replication in the human host when they cross the species barrier.
-
Aim 3: Finally, DELV will discover viral elements favoring deltavirus host shifting and adaptation capacities.
Implications
DELV aims to shape novel paradigms in virology, RNA biology, and host-pathogen interactions. Knowledge generated through DELV will guide the development of novel antiviral strategies and will have profound implications for understanding the ecology and evolution of these newly discovered, yet mysterious, viral elements.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.500.000 |
Totale projectbegroting | € 1.500.000 |
Tijdlijn
Startdatum | 1-10-2022 |
Einddatum | 30-9-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Evolutionary immunology: using insect models to unravel STING-dependent conserved and innovative antiviral strategiesThis project aims to explore antiviral gene diversity in insects, leveraging cGAMP-triggered responses in Drosophila to identify novel antiviral mechanisms for potential therapeutic applications. | ERC Advanced... | € 2.396.099 | 2025 | Details |
Archaeal Virology: unravelling the mechanisms of interviral warfareThis project aims to investigate viral mechanisms that enable competition among viruses infecting archaea, with potential applications in enhancing human health and reducing methane emissions. | ERC Starting... | € 1.500.000 | 2022 | Details |
The Multitudes of Mosquito Viruses and Their Impact on Arbovirus Disease EcologyThis project aims to explore the biology and ecology of mosquito-specific viruses to understand their interactions with arboviruses and mosquitoes, potentially improving arbovirus transmission control. | ERC Starting... | € 1.500.000 | 2025 | Details |
Dynamics and heterogeneity of early viral infectionThis project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Host-virus interactions in marine diatoms across environmental and ecophysiological gradientsThe project aims to investigate how environmental factors influence diatom host-virus interactions, enhancing understanding of their role in the ocean's carbon cycle and response to climate change. | ERC Starting... | € 1.868.196 | 2023 | Details |
Evolutionary immunology: using insect models to unravel STING-dependent conserved and innovative antiviral strategies
This project aims to explore antiviral gene diversity in insects, leveraging cGAMP-triggered responses in Drosophila to identify novel antiviral mechanisms for potential therapeutic applications.
Archaeal Virology: unravelling the mechanisms of interviral warfare
This project aims to investigate viral mechanisms that enable competition among viruses infecting archaea, with potential applications in enhancing human health and reducing methane emissions.
The Multitudes of Mosquito Viruses and Their Impact on Arbovirus Disease Ecology
This project aims to explore the biology and ecology of mosquito-specific viruses to understand their interactions with arboviruses and mosquitoes, potentially improving arbovirus transmission control.
Dynamics and heterogeneity of early viral infection
This project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies.
Host-virus interactions in marine diatoms across environmental and ecophysiological gradients
The project aims to investigate how environmental factors influence diatom host-virus interactions, enhancing understanding of their role in the ocean's carbon cycle and response to climate change.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Ontwikkeling on site diagnostische tools, vaccins en virale remmers ter bestrijding van het westnijlvirus bij mens en dierDit project richt zich op de ontwikkeling van snelle diagnostische testen en vaccins tegen het Westnijlvirus om infecties bij mens en dier te diagnosticeren, voorkomen en behandelen. | Mkb-innovati... | € 90.146 | 2022 | Details |
THERAPRODit project richt zich op het ontwikkelen van een behandeling voor West-Nile- en Chikungunya-virusinfecties door innovatieve screening van stoffen, om de virusvermenigvuldiging te stoppen. | Mkb-innovati... | € 163.275 | 2019 | Details |
Hacking the ribosome to map virus-host associationsThe VirHoX project aims to map virus-host associations using a novel technique, VirHo-seq, to enhance understanding of viral interactions and address challenges posed by emerging pathogens. | EIC Pathfinder | € 3.000.000 | 2025 | Details |
The first broad-spectrum treatment against pandemic-prone flaviviral infections: Dengue, West-Nile and ZikaATLAS aims to develop the first broad-spectrum antiviral for flavivirus infections, conducting Phase I and IIa trials for dengue to attract pharmaceutical partnerships for commercialization. | EIC Accelerator | € 2.499.999 | 2023 | Details |
Ontwikkeling on site diagnostische tools, vaccins en virale remmers ter bestrijding van het westnijlvirus bij mens en dier
Dit project richt zich op de ontwikkeling van snelle diagnostische testen en vaccins tegen het Westnijlvirus om infecties bij mens en dier te diagnosticeren, voorkomen en behandelen.
THERAPRO
Dit project richt zich op het ontwikkelen van een behandeling voor West-Nile- en Chikungunya-virusinfecties door innovatieve screening van stoffen, om de virusvermenigvuldiging te stoppen.
Hacking the ribosome to map virus-host associations
The VirHoX project aims to map virus-host associations using a novel technique, VirHo-seq, to enhance understanding of viral interactions and address challenges posed by emerging pathogens.
The first broad-spectrum treatment against pandemic-prone flaviviral infections: Dengue, West-Nile and Zika
ATLAS aims to develop the first broad-spectrum antiviral for flavivirus infections, conducting Phase I and IIa trials for dengue to attract pharmaceutical partnerships for commercialization.